Correlation Between Madrigal Pharmaceuticals and Exelixis

Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Madrigal Pharmaceuticals and Exelixis, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Exelixis.

Diversification Opportunities for Madrigal Pharmaceuticals and Exelixis

-0.13

Correlation Coefficient

Madrigal Pharmaceuticals  Exelixis

Good diversification

The 3 months correlation between Madrigal and Exelixis is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Exelixis go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Exelixis

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.63 times more return on investment than Exelixis. However, Madrigal Pharmaceuticals is 1.63 times more volatile than Exelixis. It trades about 0.05 of its potential returns per unit of risk. Exelixis is currently generating about 0.03 per unit of risk. If you would invest  32,819  in Madrigal Pharmaceuticals on November 29, 2024 and sell it today you would earn a total of  2,769  from holding Madrigal Pharmaceuticals or generate 8.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Madrigal Pharmaceuticals  vs.  Exelixis

Madrigal Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Exelixis

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent technical and fundamental indicators, Exelixis is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Madrigal Pharmaceuticals and Exelixis

The main advantage of trading using opposite Madrigal Pharmaceuticals and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.

The idea behind Madrigal Pharmaceuticals and Exelixis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.